ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA29 | B | Tofacitinib - 5mg | 7658 | 186193/13 | XELJANZ | 5mg | 60 | Tablet | Oral | Droguerie Fattal S.A.L. | Pfizer Pharmaceuticals LLC | USA | 80,685,473 L.L | 10.71 | E1 | Pfizer Inc | USA | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA29 | G | Tofacitinib - 5mg | 11482 | 154021/1 | TRIJAN | 5mg | 60 | Tablet, film coated | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC | Jordan | 54,863,315 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |